WIM
LFCR icon

Wittenberg Investment Management’s Lifecore Biomedical LFCR Stock Holding History

Wittenberg Investment Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
314,015
+12,200
+4% +$61.5K 0.56% 29
2026
Q1 		$1.12M Buy
301,815
+280,092
+1,289% +$1.93M 0.42% 39
2025
Q4 		$178K Buy
21,723
+4,500
+26% +$33.3K 0.07% 70
2025
Q3 		$127K Hold
17,223
– – 0.05% 74
2025
Q2 		$140K Buy
17,223
+5,000
+41% +$33.7K 0.06% 73
2025
Q1 		$86K Buy
12,223
+1,000
+9% +$6.21K 0.04% 73
2024
Q4 		$83.4K Sell
11,223
-46,673
-81% -$298K 0.03% 73
2024
Q3 		$285K Buy
57,896
+42,967
+288% +$224K 0.09% 71
2024
Q2 		$76.6K Buy
+14,929
New +$88.4K 0.03% 81

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Wittenberg Investment Management's LFCR Position: Q2 2026 in Review

Wittenberg Investment Management increased its Lifecore Biomedical (LFCR) stake by 4% in Q2 2026, buying an estimated $61.5K and bringing the position to 314,015 shares worth $1.65M. The position accounts for 0.56% of the portfolio, ranked #29.

Wittenberg Investment Management first reported a position in LFCR in Q2 2024 and has held it in 9 quarters since. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Wittenberg Investment Management held 314,015 shares of Lifecore Biomedical worth $1.65M as of Q2 2026.
  • Wittenberg Investment Management bought 12,200 Lifecore Biomedical shares in Q2 2026, an estimated $61.5K.
  • Lifecore Biomedical made up 0.56% of Wittenberg Investment Management's portfolio in Q2 2026, its #29 holding.
  • Wittenberg Investment Management first reported a position in Lifecore Biomedical in Q2 2024 and has held it in 9 quarters since.
  • 99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Wittenberg Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.